Doseology Sciences Inc., through its subsidiary, Dose Labs Inc., develops and sells oral stimulant products designed to support energy, focus, and cognitive performance. The company offers medicinal mushroom products, tinctures, and brain-focused nutritional and wellness products, and markets products under the Feed That Brain brand. The company sells its products online and offline. Doseology Sciences Inc. was formerly known as Pcybin Therapeutic Inc. and changed its name to Doseology Sciences Inc. in January 2020. The company was incorporated in 2019 and is based in Kelowna, British Columbia, Canada.…
Doseology Announces Results of Its Annual General Meeting
Doseology Sciences (CNSX: MOOD) is listed on the Canadian Securities Exchange, where its shares trade in CAD. It belongs to the Biotechnology industry, part of the Healthcare sector.
The shares were at 0.0800 CAD on 20 November 2026, down 77.1% over 52 weeks. Its 52-week range is 0.0800 CAD to 1.000 CAD, and it trades at the bottom of that range.
Its market capitalisation is 646.95K CAD.
Doseology Sciences reports return on equity of -32.0% and an operating margin of 0.0%.
Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.
No upcoming events tracked.